CYV — Ceryvyn Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$15.05m
- -AU$14.97m
- AU$0.00m
Annual cashflow statement for Ceryvyn Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | R2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Changes in Working Capital | 1.05 | 5.06 | 5.53 | 9.13 | 1.18 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -98.4 | -179 | -246 | -245 | -12.5 |
| Capital Expenditures | -0.023 | -0.033 | -0.051 | -0.02 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.023 | -0.033 | -0.051 | -0.02 | 0 |
| Financing Cash Flow Items | — | — | — | — | -30.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.237 | 249 | 372 | 41.3 | -30.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -101 | 66.2 | 127 | -185 | -43.9 |